ketorolac has been researched along with piroxicam in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (18.75) | 18.2507 |
2000's | 8 (25.00) | 29.6817 |
2010's | 17 (53.13) | 24.3611 |
2020's | 1 (3.13) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Barton, P; Luker, T; Wenlock, MC | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Kumar, M; Sinha, VR; Thareja, S | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bastian, HL; Branebjerg, PE; Bugge, C; Ersbøll, BK; Nørholt, SE; Sindet-Pedersen, S | 1 |
Anderson, PT; Bates, GW; Carithers, RA; DeVane, GG; Lysak, SZ; Smith, ML | 1 |
Beers, H; Huss, BK; Milligan, KR; O'Hanlon, JJ | 2 |
Frölich, JC; Stichtenoth, DO | 1 |
Hunter, JC; Lashbrook, JM; Ossipov, MH; Porreca, F; Raffa, RB; Tallarida, RJ | 1 |
Browning, RA; Burgess, FW | 1 |
Du, W; Eisenach, JC; Ma, W | 1 |
Gurtskaia, G; Tsagareli, M; Tsiklauri, N | 1 |
Medvedev, VG; Petrov, VI; Sabanov, AV; Semenov, PA; Tyrsin, OIu | 1 |
Chang, JK; Ho, ML; Li, CJ; Liao, HJ; Wang, CK; Wang, GJ | 1 |
Tsagareli, MG; Tsiklauri, N; Viatchenko-Karpinski, V; Voitenko, N | 1 |
Abzianidze, E; Berishvili, V; Gurtskaia, G; Nozadze, I; Tsagareli, M; Tsiklauri, N | 1 |
Abzianidze, E; Gurtskaia, G; Nozadze, I; Tsagareli, MG; Tsiklauri, N | 1 |
Fujita, I; Kita, Y; Okumura, T; Sakakibara, A | 1 |
Brozoski, DT; Calvo, AM; Colombini-Ishikiriama, BL; Dionísio, TJ; Faria, FA; Giglio, FP; Lauris, JR; Modena, KC; Ribeiro, DA; Santos, CF; Trindade, PA | 1 |
Gurtskaia, G; Nebieridze, M; Nozadze, I; Tsagareli, MG; Tsiklauri, N | 1 |
Nalamachu, S; Wortmann, R | 1 |
Abzianidze, E; Gorgiladze, T; Nozadze, I; Tsagareli, M | 1 |
Gurtskaia, G; Nozadze, I; Tsagareli, MG; Tsiklauri, N | 1 |
Abzianidze, E; Gurtskaia, G; Nebieridze, M; Nozadze, I; Pirkulashvili, N; Tsagareli, MG; Tsiklauri, N | 1 |
Gutmann, JL; Jinatongthai, P; Nagendrababu, V; Pulikkotil, SJ; Teerawattanapong, N; Veettil, SK | 1 |
de Castro Araujo, BL; de Melo, AC; de Oliveira, JL; Noguera, WS; Rezende, JFN; Thuler, LCS | 1 |
3 review(s) available for ketorolac and piroxicam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Role of indomethacin in acute pain and inflammation management: a review of the literature.
Topics: Acute Pain; Anti-Inflammatory Agents, Non-Steroidal; Humans; Indomethacin; Inflammation; Ketorolac; Naproxen; Oxycodone; Piroxicam; Tramadol; Treatment Outcome | 2014 |
Efficacy and Safety of Oral Premedication on Pain after Nonsurgical Root Canal Treatment: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Databases, Bibliographic; Female; Humans; Ibuprofen; Ketorolac; Male; Middle Aged; Pain, Postoperative; Piroxicam; Prednisolone; Premedication; Randomized Controlled Trials as Topic; Root Canal Therapy; Sulindac; Treatment Outcome; Young Adult | 2019 |
6 trial(s) available for ketorolac and piroxicam
Article | Year |
---|---|
A randomized, double-blind, placebo-controlled, dose-response study of the analgesic effect of lornoxicam after surgical removal of mandibular third molars.
Topics: Adolescent; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Ketorolac; Mandible; Molar, Third; Pain, Postoperative; Piroxicam; Tolmetin; Tooth Extraction | 1995 |
Postoperative effects of fentanyl, ketorolac, and piroxicam as analgesics for outpatient laparoscopic procedures.
Topics: Adult; Ambulatory Surgical Procedures; Analgesics; Anesthesia Recovery Period; Double-Blind Method; Female; Fentanyl; Humans; Ketorolac; Laparoscopy; Pain, Postoperative; Piroxicam; Tolmetin | 1994 |
A comparison of the effect of intramuscular diclofenac, ketorolac or piroxicam on postoperative pain following laparoscopy.
Topics: Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Genital Diseases, Female; Humans; Injections, Intramuscular; Ketorolac; Laparoscopy; Middle Aged; Pain Measurement; Pain, Postoperative; Piroxicam; Tolmetin | 1996 |
A comparison of the effect of intramuscular diclofenac, ketorolac or piroxicam on post-operative pain following laparoscopy.
Topics: Adult; Analgesia; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Bronchial Diseases; Constriction, Pathologic; Diclofenac; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Injections, Intramuscular; Ketorolac; Kidney; Laparoscopy; Pain Measurement; Pain, Postoperative; Piroxicam; Time Factors; Tolmetin | 1996 |
[Efficacy of lornoxicam and ketorolac in the prevention and treatment of postoperative pain syndrome in neurosurgical patients].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Female; Humans; Ketorolac; Male; Middle Aged; Models, Economic; Neurosurgery; Pain Measurement; Pain, Postoperative; Patient Selection; Piroxicam; Time Factors; Treatment Outcome | 2009 |
Sublingual ketorolac and sublingual piroxicam are equally effective for postoperative pain, trismus, and swelling management in lower third molar removal.
Topics: Analysis of Variance; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Edema; Female; Humans; Ketorolac; Male; Mandible; Molar, Third; Osteotomy; Pain Measurement; Pain, Postoperative; Piroxicam; Tooth, Impacted; Treatment Outcome; Trismus; Young Adult | 2012 |
23 other study(ies) available for ketorolac and piroxicam
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Lipophilicity of acidic compounds: impact of ion pair partitioning on drug design.
Topics: Acids; Albumins; Drug Design; Humans; Hydrogen-Ion Concentration; Lipids; Molecular Structure; Pharmaceutical Preparations; Protein Binding | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Self-organizing molecular field analysis of NSAIDs: assessment of pharmacokinetic and physicochemical properties using 3D-QSPkR approach.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemical Phenomena; Computational Biology; Least-Squares Analysis; Models, Molecular; Molecular Conformation; Quantitative Structure-Activity Relationship | 2012 |
Anesthesiology.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Ibuprofen; Ketorolac; Pain, Postoperative; Piroxicam; Tolmetin | 1998 |
Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats.
Topics: Analgesics, Opioid; Animals; Cyclooxygenase Inhibitors; Drug Synergism; Hyperalgesia; Injections, Spinal; Isoenzymes; Ketorolac; Male; Morphine; Neuralgia; Nitrobenzenes; Pain Threshold; Piroxicam; Rats; Rats, Sprague-Dawley; Spinal Nerves; Sulfonamides; Tolmetin | 1999 |
Nonsteroidal anti-inflammatory drugs for perioperative pain control.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Butanones; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Etodolac; Humans; Ibuprofen; Indomethacin; Ketorolac; Lactones; Nabumetone; Naproxen; Pain, Postoperative; Piroxicam; Pyrazoles; Sulfonamides; Sulfones; Time Factors | 2001 |
Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Hyperalgesia; Isoenzymes; Ketorolac; Ligation; Mechanoreceptors; Nerve Tissue Proteins; Nitrobenzenes; Piroxicam; Prostaglandin-Endoperoxide Synthases; Sciatic Nerve; Spinal Cord; Sulfonamides | 2002 |
Study of non-opioid analgesics tolerance in young and adult rats.
Topics: Age Factors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dipyrone; Drug Tolerance; Ketorolac; Lysine; Morphine; Nociceptors; Piroxicam; Rats; Time Factors | 2008 |
Anti-inflammatory drugs suppress proliferation and induce apoptosis through altering expressions of cell cycle regulators and pro-apoptotic factors in cultured human osteoblasts.
Topics: Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Celecoxib; Cell Cycle; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Dexamethasone; Diclofenac; Dose-Response Relationship, Drug; Humans; Immunohistochemistry; Indomethacin; Ketorolac; L-Lactate Dehydrogenase; Osteoblasts; Piroxicam; Propidium; Pyrazoles; RNA, Messenger; Sulfonamides; Thymidine | 2009 |
Non-opioid tolerance in juvenile and adult rats.
Topics: Age Factors; Analgesics; Analgesics, Opioid; Animals; Behavior, Animal; Drug Tolerance; Ketorolac; Morphine; Naloxone; Piroxicam; Rats; Time Factors | 2010 |
Tolerance induced by non-opioid analgesic microinjections into rat's periaqueductal gray and nucleus raphe.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dipyrone; Drug Tolerance; Ketorolac; Male; Microinjections; Pain Measurement; Periaqueductal Gray; Piroxicam; Raphe Nuclei; Rats | 2010 |
Opioid sensitivity of nucleus raphe magnus ater analgesia by nonsteroidal anti-inflammatory drugs.
Topics: Analgesia; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dipyrone; Drug Interactions; Drug Tolerance; Ketorolac; Male; Microinjections; Morphine; Naloxone; Nociceptors; Pain; Periaqueductal Gray; Piroxicam; Raphe Nuclei; Rats; Spinal Cord | 2011 |
Involvement of inflammation in severe post-operative pain demonstrated by pre-surgical and post-surgical treatment with piroxicam and ketorolac.
Topics: Analgesics, Opioid; Animals; Cyclooxygenase Inhibitors; Disease Models, Animal; Edema; Hyperalgesia; Inflammation; Ketorolac; Male; Morphine; Pain Threshold; Pain, Postoperative; Piroxicam; Preoperative Care; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Wounds, Penetrating | 2012 |
Antinociceptive tolerance to NSAIDs microinjected into dorsal hippocampus.
Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Diclofenac; Drug Resistance; Hippocampus; Ketorolac; Male; Microinjections; Naloxone; Narcotic Antagonists; Pain; Piroxicam; Rats; Rats, Wistar | 2014 |
NON-STEROIDAL ANTI-INFLAMMATORY DRUGS'S ANTINOCICEPTION MEDIATED BY THE OPIOID MECHANISM IN THE NUCLEUS RAPHE MAGNUS.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dipyrone; Ketorolac; Male; Microinjections; Naloxone; Narcotic Antagonists; Nociception; Nucleus Raphe Magnus; Opioid Peptides; Piroxicam; Rats; Reaction Time | 2017 |
Non-steroidal anti-inflammatory drugs attenuate agonist-evoked activation of transient receptor potential channels.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Diclofenac; Disease Models, Animal; Hyperalgesia; Ketorolac; Male; Piroxicam; Rats; Rats, Wistar; Time Factors; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPV Cation Channels | 2018 |
Antinociceptive tolerance to NSAIDs in the anterior cingulate cortex is mediated via endogenous opioid mechanism.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Tolerance; Gyrus Cinguli; Ketorolac; Male; Microinjections; Naloxone; Narcotic Antagonists; Opioid Peptides; Pain; Piroxicam; Rats, Wistar | 2018 |
Impact of Non-Steroidal Anti-Inflammatory Drugs on Recurrence and Survival after Melanoma Surgery: A Cohort Study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Female; Humans; Isoxazoles; Kaplan-Meier Estimate; Ketorolac; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Recurrence, Local; Perioperative Period; Piroxicam; Retrospective Studies; Sentinel Lymph Node Biopsy; Skin Neoplasms; Treatment Outcome | 2020 |